Showing results (271-280 of 1,042) with videos related to
Sort By:
Pageof 105
ALTEX|December 2, 2011
A replacement-first approach to toxicity testing is necessary to successfully reauthorize TSCAPaul A Locke, D Bruce MyersALTEX|December 2, 2011
The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakageMaría Moreno-Villanueva, Tobias Eltze, Dirk Dressler, et al.ALTEX|July 1, 2009
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammationAnja Henn, Søren Lund, Maj Hedtjärn, et al.ALTEX|July 1, 2009
Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro - an overviewMahtab Bahramsoltani, Johanna Plendl, Pawel Janczyk, et al.ALTEX|October 22, 2021
Animal metrics: Tracking contributions of new approach methods to reduced animal useM Sue Marty, Amanda K Andrus, Katherine A GroffALTEX|July 8, 2019
Machine learning prediction of cyanobacterial toxin (microcystin) toxicodynamics in humansStefan Altaner, Sabrina Jaeger, Regina Fotler, et al.ALTEX|April 12, 2022
Corrigendum to TBBPA Targets Converging Key Events of Human Oligodendrocyte Development Resulting in Two Novel AOPsJördis Klose, Julia Tigges, Stefan Masjosthusmann, et al.ALTEX|April 11, 2022
The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessary… and possibleManuela Cassotta, Hugo Geerts, Lise Harbom, et al.ALTEX|April 11, 2022
Next-generation risk assessment of chemicals - Rolling out a human-centric testing strategy to drive 3R implementation: The RISK-HUNT3R project perspectiveGiorgia Pallocca, Martijn J Moné, Hennicke Kamp, et al.ALTEX|April 11, 2022
Integrated skin sensitization assessment based on OECD methods (I): Deriving a point of departure for risk assessmentAndreas Natsch, George Frank GerberickPageof 105